A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression

被引：1
作者：
Can, Adem T. T. [1 ]
Hermens, Daniel F. F. [1 ]
Lagopoulos, Jim [1 ]
机构：
[1] Univ Sunshine Coast, Thompson Inst, Birtinya, QLD, Australia
来源：
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词：
depression; ketamine; MADRS; NMDA; suicidality; treatment-resistant; TRIAL; DISORDER; STRESS;
D O I：
10.1002/ccr3.6675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.
引用
收藏
页数：6
相关论文
共 50 条
[21]   Serial infusions of low-dose ketamine for major depression [J].
Rasmussen, Keith G. ;
Lineberry, Timothy W. ;
Galardy, Christine W. ;
Kung, Simon ;
Lapid, Maria I. ;
Palmer, Brian A. ;
Ritter, Matthew J. ;
Schak, Kathryn M. ;
Sola, Christopher L. ;
Hanson, Allison J. ;
Frye, Mark A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (05) :444-450
[22]   Ketamine - A New Treatment Option for Therapy-Resistant Depression [J].
Koehler, S. ;
Betzler, F. .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (02) :91-97
[23]   Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review [J].
Kwasny, Aleksander ;
Wlodarczyk, Adam ;
Ogonowski, Damian ;
Cubala, Wieslaw Jerzy .
PHARMACEUTICALS, 2023, 16 (04)
[24]   Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine [J].
Liu, Linda Xing Yu ;
Golts, Marina ;
Fernandes, Virginia .
PHARMACY, 2021, 9 (03)
[25]   Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment [J].
Kwasny, Aleksander ;
Cubala, Wieslaw Jerzy ;
Wlodarczyk, Adam ;
Pastuszak, Krzysztof .
PHARMACOLOGICAL REPORTS, 2024, 76 (06) :1325-1332
[26]   Low-dose ketamine improved brain network integrity among patients with treatment-resistant depression and suicidal ideation [J].
Su, Tung-Ping ;
Cheng, Li-Kai ;
Tu, Pei-Chi ;
Chen, Li-Fen ;
Lin, Wei-Chen ;
Li, Cheng-Ta ;
Bai, Ya-Mei ;
Tsai, Shih-Jen ;
Chen, Mu-Hong .
PSYCHIATRY RESEARCH, 2025, 345
[27]   Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression [J].
Slupski, Jakub ;
Cubala, Wieslaw Jerzy ;
Gorska, Natalia ;
Slupska, Anita ;
Galuszko-Wegielnik, Maria .
BRAIN SCIENCES, 2020, 10 (12) :1-9
[28]   Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression [J].
Galuszko-Wegielnik, Maria ;
Chmielewska, Zuzanna ;
Jakuszkowiak-Wojten, Katarzyna ;
Wiglusz, Mariusz S. ;
Cubala, Wieslaw J. .
BRAIN SCIENCES, 2023, 13 (01)
[29]   Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression [J].
Kang, M. ;
Hawken, E. ;
Bahji, A. ;
Brietzke, E. ;
Vazquez, G. .
EUROPEAN PSYCHIATRY, 2020, 63 :S113-S113
[30]   Magnesium in Ketamine Administration in Treatment-Resistant Depression [J].
Gorska, Natalia ;
Cubala, Wieslaw Jerzy ;
Slupski, Jakub ;
Wiglusz, Mariusz Stanislaw ;
Galuszko-Wegielnik, Maria ;
Kawka, Mateusz ;
Grzegorzewska, Agata .
PHARMACEUTICALS, 2021, 14 (05)
12345